Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

A groundbreaking development in hypertension treatment has emerged from the University of South Wales, offering new hope for the 1.28 billion adults worldwide affected by high blood pressure.

Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...

A speaker highlighted key advances in the treatment of hypertension in 2024. Topics included insights on the timing of blood pressure medication; impact of bariatric surgery vs. medical therapy on ...

Dr. Gilbert J. Zoghbi MD, FACC, FSCAI discusses renal denervation, an FDA-approved, catheter-based procedure that safely ...

The AHA’s Target BP initiative is a movement to increase blood pressure control among adults living with hypertension in the United States.

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

Once a diagnosis is confirmed, the next stage is to calculate personalised BP targets and cardiovascular risks, and explore treatment options for individuals with hypertension (Mancia et al, 2023; ...

Treatment of systolic hypertension in the elderly should be based on nonpharmacological measures and medical therapy if the systolic hypertension cannot be controlled by conservative therapy alone.

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines for blood pressure coexist, emanating from European,1,2 North American,3 ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...